Newfound Research’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-10
| Closed | -$2K | – | 89 |
|
|
2020
Q1 | $2K | Hold |
10
| – | – | ﹤0.01% | 37 |
|
|
2019
Q4 | $3K | Sell |
10
-7
| -41% | -$2.1K | ﹤0.01% | 71 |
|
|
2019
Q3 | $4K | Sell |
17
-1
| -6% | -$235 | ﹤0.01% | 74 |
|
|
2019
Q2 | $5K | Sell |
18
-1
| -5% | -$278 | ﹤0.01% | 62 |
|
|
2019
Q1 | $5K | Sell |
19
-2
| -10% | -$526 | ﹤0.01% | 52 |
|
|
2018
Q4 | $5K | Sell |
21
-1
| -5% | -$238 | ﹤0.01% | 34 |
|
|
2018
Q3 | $6K | Sell |
22
-1
| -4% | -$273 | ﹤0.01% | 64 |
|
|
2018
Q2 | $5K | Sell |
23
-1
| -4% | -$217 | ﹤0.01% | 56 |
|
|
2018
Q1 | $5K | Buy |
24
+3
| +14% | +$625 | ﹤0.01% | 57 |
|
|
2017
Q4 | $5K | Sell |
21
-1
| -5% | -$238 | ﹤0.01% | 71 |
|
|
2017
Q3 | $4K | Hold |
22
| – | – | ﹤0.01% | 69 |
|
|
2017
Q2 | $4K | Buy |
22
+1
| +5% | +$182 | ﹤0.01% | 75 |
|
|
2017
Q1 | $4K | Sell |
21
-1
| -5% | -$190 | ﹤0.01% | 75 |
|
|
2016
Q4 | $3K | Sell |
22
-1
| -4% | -$136 | ﹤0.01% | 70 |
|
|
2016
Q3 | $3K | Hold |
23
| – | – | ﹤0.01% | 81 |
|
|
2016
Q2 | $3K | Buy |
+23
| New | +$3K | ﹤0.01% | 74 |
|